AU  - Rosenheck RA
TI  - Outcomes, costs, and policy caution: A commentary on the cost utility of the latest antipsychotic drugs in schizophrenia study (cutlass 1)
PT  - JOUR
DP  - 2006
TA  - Archives of General Psychiatry
pages = {1074-1076},
VI  - 63
IP  - 10
AID  - 10.1001/archpsyc.63.10.1074 [doi]
4100  - http://dx.doi.org/10.1001/archpsyc.63.10.1074
SO  - Archives of General Psychiatry October 1, 2006 63(10):1074